The Synapse Project
NCT: NCT04871074 · COMPLETED
Brief Summary
The overarching goal of this project is to use \[C-11\]UCB-J to obtain spatial information on neuronal synapse abundance and inform Alzheimer's disease (AD) progression. The investigators propose to collect longitudinal amyloid, tau, and Synaptic vesicle glycoprotein 2A (SV2A) positron emission tomography (PET) in participants in the Wisconsin Alzheimer's Disease Research Center (ADRC) and Wisconsin Registry for Alzheimer's Prevention (WRAP) across the clinical stages of AD, including cognitively unimpaired biomarker negative, unimpaired biomarker positive, mild cognitive impairment (MCI), and dementia due to AD.
Frequently Asked Questions
What is The Synapse Project?
The Synapse Project is a clinical trial registered under NCT04871074. Current status: COMPLETED.
What is the status of NCT04871074?
The current status of NCT04871074 (The Synapse Project) is: COMPLETED.
When did The Synapse Project start?
The Synapse Project started on 2018-11-18.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.